Advanced Hodgkin Lymphoma: a New Era of Therapy

por Dann, Eldad J.
Publicado 2014

Hodgkin Disease—An Ever-Evolving Therapy

por Dann, Eldad J.
Publicado 2014

The Legacy of Thomas Hodgkin Is Still Relevant 150 Years After His Death. Nothing of Humanity Was Foreign to Him

por Dann, Eldad J.
Publicado 2017

Hemotransfusion in Combat Trauma

por Dann, Eldad J.
Publicado 2011

Noninvasive imaging of flowing blood cells using label-free spectrally encoded flow cytometry

por Golan, Lior, Yeheskely-Hayon, Daniella, Minai, Limor, Dann, Eldad J, Yelin, Dvir
Publicado 2012

Reduction of the Vertebral Bone Mineral Density in Patients with Hodgkin Lymphoma Correlates with Their Age and the Treatment Regimen They Received

por Ofshenko, Nadav, Bercovich, Eyal, Mashiach, Tania, Weiler-Sagie, Michal, Militianu, Daniela, Dann, Eldad J.
Publicado 2022

Patients with Hodgkin Lymphoma Develop Adequate Humoral Serological Response to Vaccination with Two Doses of BNT162b2

por Dann, Eldad J, Inbar, Tsofia, Mashiach, Tania, Eisa, Jamela, Harlev, Shimrit Ringelstein, Horowitz, Netanel A
Publicado 2021

In vivo noninvasive microscopy of human leucocytes

por Winer, Matan M., Zeidan, Adel, Yeheskely-Hayon, Daniella, Golan, Lior, Minai, Limor, Dann, Eldad J., Yelin, Dvir
Publicado 2017

Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians

por Kleinstern, Geffen, Abu Seir, Rania, Perlman, Riki, Khatib, Areej, Abdeen, Ziad, Elyan, Husein, Nirel, Ronit, Amir, Gail, Ramlawi, Asad, Sabatin, Fouad, Boffetta, Paolo, Dann, Eldad J., Kedmi, Meirav, Ellis, Martin, Nagler, Arnon, Ben Yehuda, Dina, Paltiel, Ora
Publicado 2017

Donor cell leukemia: is reappearance of gene mutations in donor cells more than an incidental phenomenon?

por Gabay, Tal Shahar, Chapal-Ilani, Noa, Moskovitz, Yoni, Biezuner, Tamir, Oron, Barak, Brilon, Yardena, Fridman-Dror, Anna, Sabah, Rawan, Balicer, Ran, Tanay, Amos, Mendelson-Cohen, Netta, Dann, Eldad J., Fineman, Riva, Kaushansky, Nathali, Yehudai-Reshef, Shlomit, Zuckerman, Tsila, Shlush, Liran I.
Publicado 2020

Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies

por Gurion, Ronit, Rozovski, Uri, Itchaki, Gilad, Gafter-Gvili, Anat, Leibovitch, Chiya, Raanani, Pia, Ben-Zvi, Haim, Szwarcwort, Moran, Taylor-Abigadol, Mor, Dann, Eldad J., Horesh, Nurit, Inbar, Tsofia, Tzoran, Inna, Lavi, Noa, Fineman, Riva, Ringelstein-Harlev, Shimrit, Horowitz, Netanel A.
Publicado 2021